no code implementations • 5 May 2024 • Nikita Shvetsov, Anders Sildnes, Lill-Tove Rasmussen Busund, Stig Dalen, Kajsa Møllersen, Lars Ailo Bongo, Thomas K. Kilvaer
Addressing the critical need for accurate prognostic biomarkers in cancer treatment, quantifying tumor-infiltrating lymphocytes (TILs) in non-small cell lung cancer (NSCLC) presents considerable challenges.